Readers are strongly advised to consult with a qualified healthcare professional before making any decisions regarding their health, including the use of GLP-1 receptor agonists or any other medication discussed herein
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled trial
Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease
Serious hypersensitivity reactions such as anaphylaxis and angioedema have occurred
encourages healthcare providers to prescribe glucagon-like peptide 1 (GLP-1) analogues
Unlike crash diets or extreme calorie restriction, these medications work by regulating hunger hormones to reduce cravings and help you feel full longer on a healthy, nutrient-dense dietmaking it easier to adopt long-term healthy habits